One can only cross one’s fingers and hope that Merck is really onto something with its new potential drug for Alzheimer’s disease. In a press briefing last week, the New Jersey-based pharmaceutical giant updated the media on some of its…
One can only cross one’s fingers and hope that Merck is really onto something with its new potential drug for Alzheimer’s disease. In a press briefing last week, the New Jersey-based pharmaceutical giant updated the media on some of its…